Skip to Main Content

NEWS & RESOURCES

Bioscience

Positive Session for Bioscience Sector

The 2026 General Assembly session was one of the least contentious in recent memory for the biopharma sector. Bills calling for innovation-sapping price controls and unworkable programs…

Boehringer Partners on Connecticut Science Center STEM Lab

The Connecticut Science Center is home to exhibits, programs, and…

Costly Public Option Precursor Advances

The Connecticut General Assembly is exploring ways to address rising…

Content Type:

Bioscience

Healthcares-Frontline-Panel 051022-1

Healthcare’s Future: Lessons from the Pandemic

Change was the dominant theme at CBIA’s May 10...

Bioscience

Lawmakers Send Biopharma Mixed Signals

The post-mortem on the 2022 General Assembly session as...

Bioscience

Healthcare’s Future in a Post-COVID World

COVID’s impact on us—the waves of infection and sickness,...

Bioscience

Committee Fails to Act on Bill Opening R&D Tax Credit to Small Business

The General Assembly’s Finance, Revenue, and Bonding Committee failed...

Aerospace

CT's Top 10 Export Destinations 2021 graph

Exports Rebound Partially from Pandemic Disruptions

Connecticut commodity exports grew to $14.6 billion in 2021,...

Bioscience

Connecticut Moving Forward with Psychedelic-Assisted Therapy

The following article was first posted in the Behavioral...

Aerospace

Report: Costs Limit Manufacturing Competitiveness

The United States is the fifth-best country for operating...

Bioscience

A Psychedelic Future

The class of drugs known as psychedelics—LSD, psilocybin (mushrooms),...

Bioscience

ReadyCT Career Pathway Programs Tackle Labor Shortage

First-year Hartford Public High School students have a big...

Stay Connected with CBIA News Digests

The latest news and information delivered directly to your inbox.